T1D Exchange Announces 13 Real-World Data Presentations and Posters at the American Diabetes Association (ADA) 85th Scientific Sessions
Studies underscore advances in screening, mental health, health equity, and early intervention in diabetes care.
New study examines benefits of continuous glucose monitoring (CGM) in people with type 2 diabetes (T2D) using glucagon-like peptide-1 (GLP-1) therapy.
Company strengthens leadership in type 1 diabetes (T1D) and T2D research, with more than 100 publications since 2020.
BOSTON, June 11, 2025 /PRNewswire/ -- T1D Exchange, a nonprofit organization that drives meaningful research and improvement in care and outcomes in type 1 diabetes (T1D) and type 2 diabetes (T2D), today announced that new research using real-world data from its Quality Improvement Collaborative (T1DX-QI) and online patient Registry will be shared during 13 presentations at the American Diabetes Association (ADA) 85th Scientific Sessions being held June 20-23, 2025, in Chicago, Illinois.
The studies highlight emerging trends and outcomes in diabetes care, including efforts to improve screening for T1D autoantibodies, technology usage, particularly CGMs, and the increased use of GLP-1 therapies by individuals with T2D. Drawing on data from the organization's Registry of more than 20,000 people with T1D, several presentations offer insights into clinical outcomes as well as the broader impact of the disease, including financial strain, mental health challenges, and comorbid conditions. A full list of abstracts being presented is available here.
"We are excited to unveil impactful research driven by our growing T1DX-QI network and robust patient Registry," said David Walton, Chief Executive Officer of T1D Exchange. "By uniting over 60 endocrinology clinics, data from 150,000+ individuals with T1D and T2D, and patient-reported outcomes from people with T1D and their caregivers, we're building a collaborative, evidence-driven knowledge base to expand our capabilities, deepen datasets, and generate insights that improve care for people with diabetes."
Key studies include an oral presentation exploring equitable strategies to increase CGM adoption by people with T2D, expanding on prior research in T1D:
276-OR, T1D Exchange Multicenter Study—Increasing CGM Adoption in Type 2 Diabetes on Sunday, June 22, 3:15 - 4:15 p.m. CT in Room W185 A-D
Additionally, data from 12 studies will be presented during the General Poster Sessions on Saturday, June 21, Sunday, June 22, and Monday, June 23, from 12:30 - 1:30 p.m. CT in Poster Hall F1.
"Many of our presentations this year highlight the strength of our engaged T1D community and the value of our growing Registry. Thousands of participants contributed to research that explores the financial, emotional, and clinical realities of living with T1D," said Wendy Wolf, PhD, Vice President of Registry and Outcomes Research at T1D Exchange. "Our Registry not only provides real-world, patient-reported insights, but also serves as a powerful platform for targeted study recruitment, enabling partners to accelerate research that is closely aligned with patient needs. Our Registry has helped recruit for dozens of research studies, including 16 clinical trials – with more than 10,000 Registry participants enrolled in external studies to date."
About the T1DX-QI and the T1D Exchange RegistryThe T1D Exchange Quality Improvement Collaborative (T1DX-QI) brings together 60+ endocrinology clinics across the U.S., collectively treating more than 150,000 people living with type 1 and type 2 diabetes, to identify and address gaps in care and accelerate evidence-based, practical solutions. Participating clinics contribute anonymized patient data and insights from their respective clinics, expanding the collective knowledge base and creating a unified data asset to expedite improvements in care for all people living with type 1 and type 2 diabetes.
The T1D Exchange Registry is an online longitudinal study that tracks disease progress and gathers information directly from people with type 1 diabetes and caregivers of children with type 1 diabetes. To date, the Registry includes over 20,000 participants in the U.S. These individuals share patient-reported outcomes, including data on disease management. Participants update their information annually, participate in internal research projects, and are connected to external curated research opportunities, including clinical trials. The online Registry is designed to lower barriers to participating in diabetes research, including patient populations often underrepresented in clinical studies.
The T1DX-QI and T1D Exchange Registry have contributed to more than 100 publications by T1D Exchange in leading medical journals since 2020.
About T1D ExchangeT1D Exchange is a leader in harnessing data to advance diabetes care and outcomes by driving collaborative change. Through real-world evidence and clinical data collection and analysis, its programs provide novel insights that identify gaps in care and refine best practices to improve the lives of those living with diabetes. T1D Exchange supports quality improvement and innovation through its Quality Improvement Collaborative (T1DX-QI), online patient Registry, and data-oriented research services. Through a knowledge-sharing and collaboration-focused approach, T1D Exchange accelerates real-world impact by providing clinicians, researchers, industry partners, and advocates with the resources and services they need for better decision support and population health management. T1D Exchange is a nonprofit organization established in 2010 with ongoing support from The Leona M. and Harry B. Helmsley Charitable Trust.
To learn more about T1DX-QI member clinics, click here. For more information on the Registry, visit t1dregistry.org.
Media Contact:Suzanne McKeeDirector of Marketing, T1D ExchangePhone: 617-671-0429Email: smcKee@t1dexchange.org
View original content to download multimedia:https://www.prnewswire.com/news-releases/t1d-exchange-announces-13-real-world-data-presentations-and-posters-at-the-american-diabetes-association-ada-85th-scientific-sessions-302478361.html
SOURCE T1D Exchange
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Hairstylists and medical expert confirm temporary hair loss affecting Ozempic users
Side effects from GLP-1s can vary — but one lesser-known reported outcome of the popular weight-loss medications is hair loss or thinning. Some hairstylists have confirmed an uptick in clients who complain about losing hair while on weight-loss journeys. This includes Ashley DiMatteo, owner of Ashley Lauren Beauty Lounge in Westchester, New York, and Briana Delvecchio, a color specialist and hairdresser at DiMatteo's salon. The two spoke with Fox News Digital in an on-camera interview (see the video at the top of the article). Is Ozempic Ruining Your Teeth? What To Know About Impact On Dental Health "There has definitely been an increase in clients coming in with hair loss," DiMatteo said, noting that it ranges from gradual to fast, and from thinning out to completely losing hair. Delvecchio agreed that she's had "a few" clients come in reporting thinner and drier hair, which she suspects could be due to weight-loss drugs. Read On The Fox News App The hairstylist, who herself takes a GLP-1 drug, said there may be a few reasons for hair changes — including new medications, vitamin deficiencies and weight loss, which can put stress on the body. Becky Watt, an Ohio hairstylist with more than 20 years of experience, said she has also noticed clients losing hair while taking weight-loss drugs. "I've seen thinning and shedding, and a lot of hair coming out very easily when being washed," she told Fox News Digital. "I have not noticed any bald spots." However, she has had some clients who are taking the medications without any hair loss, Watt added. In a separate interview, Dr. Philip Rabito, an endocrinologist in New York City, explained that this reaction, called telogen effluvium, is a stress response to weight loss that affects the hair follicle. Ozempic, Other Semaglutides Linked To Hair Loss: Here's What To Know The response is only temporary, he noted — the hair will fall out and then grow back once the weight loss stabilizes after a few months. "It's a response to severe physical stress — and weight loss is considered starvation," Rabito said. "It is the rapidity of the weight loss that correlates with the amount of hair loss." Before weight-loss drugs, traditional bariatric surgery would lead to the loss of 70% of excess body weight in about six months, Rabito shared — which was often followed by hair loss within six to nine months. "Your body doesn't understand that this is healthy weight loss — your body thinks it's starving," he reiterated. "It happens to almost everyone, to some people more than others." This Daily Beauty Routine Could Be Ruining Your Hair, Experts Warn Those who lose weight more repetitively are at higher risk of hair loss, Rabito said, as well as those who have an underlying thyroid issue or micronutrient deficiency — typically in iron, B12 or vitamin D. These vitamin deficiencies can worsen as weight loss occurs, so it's important to work with a medical professional to balance these levels, according to the doctor. "From what I have learned from talking to these specific clients, it seems that the clients that are still eating don't have the hair loss," Watt observed. "It seems that my clients who say they don't have any appetite whatsoever are the ones losing the most hair," she went on. "I believe that's possibly due to lack of nutrients and protein, although I'm no doctor." DiMatteo and Delvecchio agreed that they "always" advise their clients to see their doctor for a vitamin level check. "And we will also then taper their hair routine," DiMatteo said. "Basically, less is more during hair loss." The salon owner suggests keeping up with scalp treatment, reducing the use of heat, brushing from the bottom up and avoiding going to bed with wet hair. "Check in with your weight-loss doctor or your endocrinologist prior to coming to us to rule out iron, vitamin D or anything that you're lacking — we need to rule that out before we can help you," Delvecchio said. "Then we'll tell you we need to work on your scalp health; we'll give you shampoo and conditioner that may be a little gentler for your hair." "Scalp stimulation is huge," DiMatteo added. "Rinsing with cool water helps as well. Try not to do harsher treatments in the sense of lightening or coloring — spread it out as much as possible." Rabito noted that losing hair is "part of the game" — he said he always warns his patients before starting their weight-loss journey that this will most likely occur and is a "mark of success." "They're going to lose hair," he said. "It's going to get worse before it gets better." "But as long as you get the vitamins controlled, get them adequately repleted — when the patient plateaus and the weight is stable for a month or two, the body doesn't sense starvation anymore, and the body is less stressed, then the hair grows back better than ever." Watt said she often recommends a hair vitamin to her clients struggling with weight loss. "Diet also has a lot to do with it," she noted. She also recommends using a shampoo and conditioner that are formulated to resist thinning and hair loss, along with a bond-building hair product. Click Here To Sign Up For Our Health Newsletter DiMatteo and Delvecchio assured those who are experiencing hair loss that regrowth does take time, and that there's no need for excessive hair growth treatments. Delvecchio added, "The hair loss is temporary. It's a positive stress, and it's worth it." When previously contacted by Fox News Digital, Novo Nordisk — maker of Ozempic and Wegovy — confirmed that hair loss is an identified risk for semaglutide, and is listed as a side effect in the product information. "In clinical trials of Wegovy, hair loss was reported in 2.5% of Wegovy-treated adult patients versus 1.0% of placebo-treated adult patients," the company spokesperson said at the time. For more Health articles, visit "Hair loss was reported more frequently in patients with greater weight loss (≥20%), suggesting that the events of hair loss were potentially related to the magnitude of weight loss." "Patient safety is of utmost importance to Novo Nordisk," the statement continued. "We are continuously monitoring the safety profile of our products and collaborate closely with authorities to ensure patient safety, including adequate information on hair loss." Melissa Rudy contributed article source: Hairstylists and medical expert confirm temporary hair loss affecting Ozempic users
Yahoo
32 minutes ago
- Yahoo
Yesoul R1M PLUS Home Rowing Machine: A Full-Body Fitness Solution Designed for Men's Health and Everyday Life
HONG KONG, June 14, 2025 /PRNewswire/ -- Coinciding with Men's Health Month, Yesoul promotes accessible home fitness tailored for today's busy men—from young professionals to active retirees. Prioritizing Men's Health: Why It Matters More Than Ever June is recognized globally as Men's Health Month—a time dedicated to raising awareness about the physical and mental health challenges men face throughout their lives. From young professionals navigating demanding careers to fathers juggling family and work, and older men seeking longevity and vitality, men's wellness is a multifaceted issue that deserves year-round attention. Despite increasing public health campaigns, studies consistently show that men are less likely than women to seek medical advice, maintain regular fitness routines, or engage in preventive care. Factors such as time constraints, work-related stress, and cultural stigmas around masculinity contribute to rising rates of chronic illness, cardiovascular conditions, and mental health struggles. That's why accessible, tech-enhanced home fitness equipment—like the Yesoul R1 M PLUS Rowing Machine—is more essential than ever. Compact, versatile, and designed with real-life convenience in mind, the R1 M PLUS empowers men across all life stages to take control of their health, right from the comfort of their homes. The Yesoul R1 M PLUS: A Modern Rowing Machine Built for Real Life More than just a piece of exercise equipment, the R1 M PLUS is a wellness ally engineered for versatility, comfort, and intelligent fitness. With design elements tailored to support modern lifestyles, this machine helps eliminate common workout barriers, like time, space, and noise. Foldable Design That Fits Any Space One of the R1 M PLUS's standout features is its space-saving foldability. Whether you're in a city apartment, home office, or shared living area, its vertical-folding rail reduces the footprint by over 50%. Paired with smooth transport wheels, it's easy to roll the machine away when not in use—making it ideal for men with limited space or irregular routines. Full-Body, Low-Impact Workouts for All Fitness Levels Rowing is widely considered one of the most efficient full-body workouts, engaging over 80% of major muscle groups—legs, core, back, and arms—while being gentle on the joints. It's an ideal form of exercise for: Busy professionals looking to build stamina and reduce stress Dads fitting in workouts between family responsibilities Middle-aged men maintaining muscle tone and metabolic health Seniors who want a joint-friendly cardiovascular activity Silent Magnetic Resistance with 100 Intensity Levels The R1 M PLUS features a custom magnetic resistance system that delivers whisper-quiet operation with 100 adjustable levels, so users can tailor their workout intensity without disturbing others. Whether you prefer a relaxing endurance row or a sweat-inducing sprint session, this machine adapts to your goals without compromise. Immersive 21.5" Rotating Screen with Free Mirroring The heart of the R1 M PLUS experience is its 21.5-inch 1080p full HD screen. Designed to rotate 360°, it enables not only rowing sessions but also access to stretching, HIIT, yoga, and strength training classes—all in one place. A major highlight is the R1 M PLUS's Free & Unlimited Screen Mirroring feature. Without requiring any subscription, users can simply connect their devices (note: Android phones require DisplayPort support) and stream content directly onto the 21.5-inch rotating screen—from YouTube workouts to popular fitness apps like, Kinomap, or Zwift. This gives users the freedom to enjoy their favorite platforms, videos, or routines on a larger screen, completely free of charge. While some brands charge over $100 per year for app access, the Yesoul App remains affordable—offering a full library of workouts, real-time data tracking, and training features for less than the cost of a nice dinner out. And even without a subscription, users can still take full advantage of the screen mirroring feature to enhance their fitness experience at no cost. This flexibility empowers men to stay motivated and consistent while tracking workout data like stroke rate, power, distance, resistance, and calories—all from the comfort of home. Mental Fitness Matters, Too Modern masculinity means taking care of both body and mind. Rowing provides a meditative rhythm that promotes stress relief and mental clarity. Combined with scenic virtual routes or relaxing music streamed through the screen, the R1 M PLUS becomes a tool for both physical and emotional balance. Through the Yesoul app, users can enjoy mindfulness-based workouts, expert-led stretches, and calming cooldowns that promote relaxation and speed up recovery. Ergonomically Designed for Comfort, Strength, and Safety The R1 M PLUS features ergonomic handles, adjustable foot straps, and a sturdy yet minimalist frame. It's engineered to accommodate a wide range of body types and rowing styles while minimizing strain and maximizing comfort. Seamless Integration into Daily Life Quick Assembly: Easy-to-follow instructions get you started in minutes Minimalist Aesthetic: A sleek, neutral-toned design blends into modern interiors Flexible Training Modes: Rotate the screen for cross-training, stretching, or floor workouts Who Is It For? This rowing machine isn't just for one type of user. The R1 M PLUS was thoughtfully designed to support all men—across ages, goals, and lifestyles: Young Professionals: Maximize limited time with full-body workouts that boost energy and reduce sedentary stress Fathers: Stay strong, focused, and healthy with fast, effective at-home fitness Middle-Aged Men: Maintain strength, manage weight, and protect cardiovascular health as priorities shift Retirees: Improve balance, mobility, and longevity through safe, joint-friendly exercise Whether you're new to rowing or a seasoned athlete, the R1 M PLUS offers an inclusive path to consistent, long-term wellness. Yesoul's Broader Mission: Redefining Everyone By spotlighting the R1 M PLUS during Men's Health Month, Yesoul underscores its larger commitment to men's well-being. The brand is actively shifting fitness culture away from intimidation and exclusivity toward accessibility, comfort, and relevance. From smart bikes to treadmills to rowing machines, Yesoul is building an ecosystem that empowers men to prioritize self-care, redefine their health journeys, and access premium technology without premium pricing. It's More Than a Machine—It's a Mindset Shift In a world that often asks men to "tough it out," Yesoul is encouraging them to slow down, check in, and row forward—one stroke at a time. The R1 M PLUS makes fitness easier to begin, more enjoyable to maintain, and more adaptable to the realities of everyday life. Make Wellness a Year-Round Priority This June and beyond, take the next step toward better health with a tool that meets you where you are. The R1 M PLUS Rowing Machine isn't just equipment—it's a commitment to longevity, strength, and balance. Explore more at Follow Yesoul for tips, tutorials, and community stories: Instagram: @ @YESOUL FITNESS View original content to download multimedia: SOURCE Yesoul Fitness Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10 hours ago
- Yahoo
Life Science Labs Signal Shifting Strategies Amid New Economic Pressures, According to Survey of 550+ Researchers
ARLINGTON, Va., June 13, 2025 /PRNewswire/ -- New survey insights reveal a measurable shift in how life science labs are responding to global financial uncertainty, rising operational costs, and upcoming U.S. tariff policies. Based on responses from more than 550 academic and industry researchers, the latest data from BioInformatics' Beyond the Bench series captures how lab priorities, purchasing decisions, and funding strategies have evolved from January to mid-April 2025—offering a rare pre- and post-policy view of market sentiment. While the first wave of the survey was fielded prior to the announcement of new tariff policies, the second wave offers a timely comparison as labs began adjusting to anticipated policy changes under the Trump administration and broader macroeconomic pressures, including inflation, tightened research budgets, and supply chain strain. Click here to download the Lab Budgets & Funding Survey Key Survey Findings Include: Funding confidence is declining, with only 57% of labs reporting confidence in securing 2025 funding—down from 66% in the first wave. Financial strain is hitting North American labs harder than those in Europe: 46% report new funding challenges (vs. 21% in Europe), and over half are considering personnel cuts, compared to just 28% in Europe. 42% of labs cite new concerns about securing funding through year-end, signaling heightened financial risk across the sector. Cost-saving strategies are accelerating, including resource sharing, supplier renegotiations, outsourcing, and delayed equipment purchases. These findings reflect shifting institutional priorities and underscore the growing need for timely, market-aligned planning as labs face increased constraints and financial pressure. "By fielding this survey before and after key policy announcements, we're able to offer a real-time snapshot of how labs are adjusting to economic volatility," said Richa Singh, VP, Market Insights at BioInformatics. "As tariff policies begin to reshape lab planning, companies need focused, evidence-backed insights to align their strategies. This data helps commercial teams track funding sentiment, adapt messaging, and make confident, evidence-based decisions—especially in a market where priorities can change within weeks." About Beyond the Bench Beyond the Bench is a free monthly intelligence series created by BioInformatics to help life science and diagnostics companies understand how customer sentiment and commercial priorities are shifting—particularly during times of uncertainty and industry disruption. Powered by the Science Advisory Board, BioInformatics' proprietary network of over 55,000 life science professionals, each report delivers survey-based insights on market trends, strategic shifts, and buyer behavior. The series was launched to provide a clear, unbiased view into the evolving challenges facing researchers and decision-makers—giving commercial teams actionable guidance to align strategy, messaging, and resource planning with what matters most to their customers. Access & Get Involved: Download the Lab Budgets & Funding Survey Sign up to receive monthly Beyond the Bench reports Join the Science Advisory Board — qualify to participate in surveys, earn rewards, and shape the future of scientific research. About BioInformatics BioInformatics, part of the Science and Medicine Group, is a leading market research and advisory firm serving the life science and diagnostic industries. The company delivers custom and syndicated research powered by a proprietary global panel of more than 55,000 professionals. View original content to download multimedia: SOURCE BioInformatics Inc.
